e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
COPD mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alpha1-antitrypsin deficiency: An analysis of patient subgroups of the German registry
C. Guttmann, P. M. Lepper, M. Bachhuber, C. Herr, A. R. Koczulla, C. Vogelmeier, R. Bals (Homburg, Marburg, Germany)
Source:
Annual Congress 2011 - COPD mechanisms
Session:
COPD mechanisms
Session type:
Thematic Poster Session
Number:
3596
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Guttmann, P. M. Lepper, M. Bachhuber, C. Herr, A. R. Koczulla, C. Vogelmeier, R. Bals (Homburg, Marburg, Germany). Alpha1-antitrypsin deficiency: An analysis of patient subgroups of the German registry. Eur Respir J 2011; 38: Suppl. 55, 3596
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Alpha1-antitrypsin deficiency in Italy: Analysis of the Italian registry database
Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Year: 2011
Clinical phenotypes of Italian and Spanish patients with a1-antitrypsin deficiency
Source: Eur Respir J 2013; 42: 54-64
Year: 2013
Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database
Source: Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016
Year: 2017
Detection of alpha1-antitrypsin deficiency in a European country without national registry yet
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
Protocol for the EARCO Registry: a pan-European observational study in patients with a
1
-antitrypsin deficiency
Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019
Year: 2020
Genotyping and phenotyping of alpha1-antitrypsin deficiency Greek patients under augmentation therapy: a multicenter study
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Clinical and functional characteristics of Italian and Spanish patients with alpha 1-antitrypsin deficiency
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
What makes Alpha1-antitrypsin deficiency patients exacerbate: a 5-year cohort
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results.
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021
Diagnosis and management of a
1
-antitrypsin deficiency in Europe: an expert survey
Source: ERJ Open Res, 5 (1) 00171-2018; 10.1183/23120541.00171-2018
Year: 2019
Association of HLA variants with sarcoidosis in Korean population: pilot study
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
Alpha-1-antitrypsin deficiency in Kazakh subjects with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Results from the ongoing newborn screening
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Baseline characteristics of subjects with α
1
-antitrypsin deficiency included in the alpha one international registry (AIR)
Source: Eur Respir J 2003; 22: Suppl. 45, 487s
Year: 2003
Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept